Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...
BioForge and Panther Life Sciences explain how their partnership is advancing vaccine patch technology and keeping the ...
According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
The formal reports of the work conducted by the MicroArray Quality Control (MAQC) consortium lay the groundwork for microarrays to gain acceptance as a clinical diagnostic and drug development tool.
Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...
AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...
DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading DNA diagnostics companies' market shares, challenges, DNA diagnostics market ...
Smartglasses are a new consumer-tech arms race for the last and best real estate on our bodies. So what are we supposed to do with them? Jackie Jantos, Hinge chief executive, details how the dating ...
Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
The work presents a large language model-based framework for short-term city-wide traffic prediction across multiple transport modes and scenarios, demonstrating scalability, generality, and effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results